Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-02

Clinical Trial Update: REALITY LHON Registry

View source ↗

Summary

The REALITY LHON Registry clinical trial, conducted by GenSight Biologics for Leber Hereditary Optic Neuropathy, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GenSight Biologics | Conditions: Leber Hereditary Optic Neuropathy | Status: COMPLETED